BACKGROUND The measurement of circulating anti-Müllerian hormone (AMH) has been
applied to a wide array of clinical applications, mainly based on its ability to reflect the …

BACKGROUND In women, anti-Müllerian hormone (AMH) is exclusively produced by
granulosa cells of ovarian follicles during the early stages of follicle development. After an …

Importance Despite lack of evidence of their utility, biomarkers of ovarian reserve are being
promoted as potential markers of reproductive potential. Objective To determine the …

STUDY QUESTION What is the recommended management for couples presenting with
unexplained infertility (UI), based on the best available evidence in the literature …

In women,∼ 10% of cancers occur in those< 45 years old. Chemotherapy, radiotherapy and
bone marrow transplantation can cure> 90% of girls and young women with diseases that …

With our increasing appreciation that simply maximizing oocyte yield for all patients is no
longer an appropriate stimulation strategy and that age alone cannot accurately predict …

Context: Anti-müllerian hormone (AMH) is an ovarian reserve marker that is increasingly
applied in clinical practice as a prognostic and diagnostic tool. Despite increased use of …

Infertility affects approximately 13% of women and 10% of men. The major causes of female
infertility are anovulation, fallopian tube disease, pelvic adhesions, endometriosis, and …

STUDY QUESTION Is serum anti-Müllerian hormone (AMH) level predictive of cumulative
live birth (CLB) rate after ART or in women trying to conceive naturally? SUMMARY …

BACKGROUND Anti-Müllerian hormone (AMH) serum concentration and antral follicle count
(AFC), as measured by transvaginal ultrasonography, accurately reflect the antral follicle …